Tactical Underweight: Trim 25–30% into $368–$378; two-step stop at $365/$369; reload at $383.50 or $337 capitulation
Underweight is the correct synthesis: the technical posture is structurally confirmed (MACD -7.76, RSI 43, five consecutive weekly closes below falling 50 SMA, lower-high formation $427→$371→$369); the forward EPS of $19.39 producing PEG 0.35 is consensus-dependent and vulnerable to 4–6 weeks of sell-side revisions post guide miss; and the expected-value framework is dominated by left-tail risk ($250–$300) given 93% Polymarket no-cuts 2026, $100+ oil, rising yields, 1.46 beta, and trailing 47x P/E with no cushion. The 25–30% trim (vs neutral's 15–20% and trader's 40%) balances structural balance-sheet risk ($97.8B goodwill at 57% of assets) against whipsaw risk in the chop zone. Reject Buy/Overweight (09-08 Overweight produced -0.7% alpha without confirmation gates firing), Pure Hold (09-01/09-02 Holds produced -1.1%/-3.8% alpha), and the conservative's $356.18 stop (too tight to constitute patience). Upgrade to Hold/Overweight if beat-and-raise Q4 FY26 revives $19.39 EPS trajectory with close above $383.50 on volume, Anthropic IPO formalizes, Fed dovish surprise occurs, or Google TPU scope clarifies bullishly; downgrade to Sell if weekly close below $337 on expanding volume confirms lower-Bollinger breakdown.
| Position | Action |
|---|---|
| AVGO rallies to $368–$378 zone | Trim 25–30% of existing AVGO exposure (do NOT initiate fresh longs at $364) |
| Weekly close below $365 on rising volume | Trim another 25% toward $360 |
| Weekly close below 200 SMA at $369 with volume | Trim toward half position (opens path to $337 lower Bollinger, then $309) |
| Reload trigger: $383.50 reclaim with volume + MACD bullish cross | Re-enter as re-rating trade |
| Reload trigger: Bearish capitulation at $337 with exhaustion close back above $350 | Re-enter as shakeout trade |
| Tail-hedge: 6–9 month horizon | Put position in $340–$350 strike range, 5–7% notional |
AVGO's 0.35 PEG represents extraordinary undervaluation given 47.9% YoY revenue acceleration, $41B+ FCF run-rate, and a 23% drawdown that has the rising 200 SMA holding as support—making this a gift for long-term investors as AI infrastructure demand compounds.
| Indicator | Value | Signal |
|---|---|---|
| Close | $364.38 | neutral |
| RSI | 43.19 | neutral |
| MACD | -7.76 | bearish |
| MACD Histogram | -0.18 | bearish |
| MACD Signal | -7.58 | bearish |
| 10 EMA | $366.16 | bearish |
| 50 SMA | $383.57 | bearish |
| 200 SMA | $369.24 | neutral |
| Bollinger Upper Band | $409.51 | neutral |
| Bollinger Mid Band | $373.05 | neutral |
| Bollinger Lower Band | $336.59 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
EV: $400–$410 initial target; $495 stretch target · concedes: The bear is correct that Q4 FY26 guide came in light; One quarterly guide was soft; AVGO is currently below the 50 SMA ($383.57)
AVGO is a phenomenal business but a poor stock at current levels because the bull's valuation thesis rests on consensus estimates that have already been partially invalidated by a guide miss, while the technical, macro, and competitive backdrop offers no compelling entry point — the stock requires near-perfection across multiple variables with asymmetric downside risk.
EV: ~$378 (~3.7% expected return) · concedes: AVGO is a phenomenal business with real AI infrastructure exposure; Q2 FY26 revenue growth of 47.9% YoY was stellar; Capital return story is real — $17B annually supports the equity over time; Co-engineering relationships with hyperscalers are genuine; Macquarie TAM estimate of $40B from Anthropic offset is a real addressable market AVGO could pursue; The Hock Tan margin-expansion playbook has historically worked to drive profitability
→ vs conservative: PEG of 0.35 thesis is reckless because it's built on $19.39 EPS that can move 15-20% on a single Q4 print; if Q4 FY26 prints $16, PEG explodes to ~0.85 making AVGO expensive not cheap
→ vs conservative: Conservative analyst refuses to engage with price action: falling 50 SMA for 5 weeks, MACD negative 7.76, lower highs since August, Truist target cut, Q4 guide miss; sitting on full position through this is high-risk not conservative
→ vs conservative: Anthropic $40B opportunity thesis doesn't immunize stock from price action; if thesis is so obvious why is stock 23% off high and Bank of America rotating to Micron/AMD
→ vs conservative: Conservative analyst mistakes conviction for wisdom; Hock Tan being best operator doesn't mean buy at every price; stock went from 495 to 289 in a year
→ vs neutral: Waiting for confirmed break above 383 or below 356 means missing the rally into 383 where you'd trim into strength, and getting stopped out at worse prices when 356 breaks
→ vs neutral: Neutral analyst pays full price for a forecast they admit is mixed; paralysis with a Monte Carlo license plate
→ vs neutral: Their own data confirms asymmetry: ATR compressed from 17 to under 13, MACD slope flattening, RSI neutral at 43 means selling is exhausting; the move is now in the 364-373 zone not after the next $30 of action
| neutral |
| ATR | $12.88 | neutral |
| Price vs 10 EMA | Below (364.38 < 366.16) | bearish |
| Price vs 50 SMA | Below (~5.0% below) | bearish |
| Price vs 200 SMA | Below (~1.3% below) | neutral |
Support: 369.24 · 356 · 358 · 342.33 · 336.59 | Resistance: 373.05 · 383.57 · 401 · 409 · 409.51
AVGO is in a transitional zone between a healthy long-term uptrend (200 SMA rising from ~$345 in May to ~$369 today) and a confirmed medium-term downtrend (50 SMA falling from ~$412 in mid-June to $383.57). The stock has carved a step-down consolidation pattern since the Aug-07 high of $427.76, finding support repeatedly near $355-358. The 200 SMA at $369.24 is the critical line — a closing break below would be a major bearish signal, while a reclaim above the 50 SMA at $383.57 would be the first medium-term bullish confirmation. Momentum indicators show negative-but-flattening MACD (-7.76) and neutral RSI (43.19), suggesting a low-conviction environment best traded with defined risk awaiting a clearer trigger.
Market Cap
$1.73T
TTM PE Ratio
46.4x
Forward PE
18.8x
PEG Ratio
0.35
Price / Book
17.4x
EPS (TTM)
$7.85
Forward EPS
$19.39
Dividend Yield
0.71%
Beta
1.46
52-Week Range
$289.96 – $495.00
50-Day Avg
$383.73
200-Day Avg
$369.97
TTM Revenue
$89.1B
TTM Net Income
$38.26B
TTM Gross Profit
$67.29B
TTM EBITDA
$52.06B
Gross Margin (TTM)
75.5%
Operating Margin (TTM)
54.3%
Net Margin (TTM)
42.9%
ROE (TTM)
44.2%
ROA (TTM)
15.3%
TTM FCF
$30.50B
FCF Yield
~1.8%
Cash (FY2025)
$16.18B
Cash (Q2 FY26)
$19.63B
Total Debt (FY2025)
$65.14B
Total Debt (Q2 FY26)
$64.91B
Net Debt (FY2025)
$48.96B
Net Debt (Q2 FY26)
$45.28B
Stockholders' Equity (FY2025)
$81.29B
Stockholders' Equity (Q2 FY26)
$87.69B
Current Ratio (FY2025)
2.50x
Working Capital (FY2025)
$13.06B
Working Capital (Q2 FY26)
$23.35B
Goodwill (FY2025)
$97.80B
Debt/Equity
59.6x
Annual Revenue FY2021
$33.20B
Annual Revenue FY2022
$33.20B
Annual Revenue FY2023
$35.82B
Annual Revenue FY2024
$51.57B
Annual Revenue FY2025
$63.89B
Quarterly Revenue Q1 FY25
$15.00B
Quarterly Revenue Q2 FY25
$15.00B
Quarterly Revenue Q3 FY25
$15.95B
Quarterly Revenue Q4 FY25
$18.02B
Quarterly Revenue Q1 FY26
$19.31B
Quarterly Revenue Q2 FY26
$22.19B
FY2025 Net Income
$23.13B
FY2024 Net Income
$5.90B
FY2025 FCF
$26.91B
FY2025 Dividends
$11.14B
FY2025 Buybacks
$6.31B
FY2025 Total Capital Returned
$17.45B
Strengths
Concerns
Broadcom is a high-quality semiconductor and infrastructure software compounder with best-in-class margins (75.5% gross, 54.3% operating, 42.9% net) and accelerating revenue growth (+47.9% YoY in Q2 FY26 to $22.19B), driven by AI custom silicon demand from hyperscalers and VMware software integration. The company generates $30.5B TTM free cash flow, is actively deleveraging its balance sheet (net debt falling from $48.96B to $45.28B in two quarters), and returns $17-20B annually to shareholders via dividends and buybacks. The forward PE of 18.8x and PEG of 0.35 suggest the stock is not overstretched given its growth profile, though the stock is near 52-week highs with limited near-term upside without a pullback. HOLD for existing positions; add on dips toward the 50-DMA ($384) or 200-DMA ($370).
Macro: Fed policy: 93% probability of zero cuts in 2026 (+4.0pp WoW) per Polymarket; recession U.S. 8%, UK 6%, Japan 6%. Oil at $100; bond yields jumping despite $6B US government intervention. Dow Jones Futures lower on oil/yields/inflation concerns. European consumer staples expected to underperform (Deutsche Bank). Inflation data due this week. Apple iPhone-17 unveiling could provide small positive for AVGO's wireless segment.